• Mar. 2009 - Feb. 2012 BS, Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea

• Mar. 2012 - Feb. 2016 MD, Yonsei University College of Medicine, Seoul, Korea

• Sep. 2017 – Feb. 2020 PhD, Yonsei University College of Medicine, Seoul, Korea

• Thesis title: Development and evaluation of high risk group prediction model in T1 stage renal cell cancer using molecular biomarkers

• Thesis advisor: Professor Won Sik Ham

• 2016 License to Practice Medicine in Korea. #123610

• 2021 License to Urology in Korea. #2989

• Mar. 2016 - Feb. 2017 Internship, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

• May 2017 – Feb. 2021 Residency, Severance Hospital, Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

• July 1st – 28th. 2018 Visiting Residency, Johns Hopkins University School of Medicine, Department of Urology

• Mar. 2021 -  Apr. 2023 Director, Department of Urology, Sorokdo National Hospital, Ministry of Health and Welfare, Korea

• Apr. 2023 - Apr. 2024 Director, Overseas Infectious Disease Reporting Center, Incheon Airport National Quarantine Station, 

                                    Capital Regional Centers for Disease Control and Prevention, Korea Disease Control and Prevention Agency, Incheon, Korea

• May 2024 -                 Clinical fellow, Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

• Member, Korean Urological Association

• Member, European Association of Urology

• Member, American Urological Association

2014

1. Choi SB, Kwon MK, Chung JW, Park JS, Chung K, Kim DW. Effects of short-term radiation emitted by WCDMA mobile phones on teenagers and adults. BMC Public Health. 2014 May 10;14:438. doi: 10.1186/1471-2458-14-438. PMID: 24886241; PMCID: PMC4108016.

2. Choi SB, Kim WJ, Yoo TK, Park JS, Chung JW, Lee YH, Kang ES, Kim DW. Screening for prediabetes using machine learning models. Comput Math Methods Med. 2014;2014:618976. doi: 10.1155/2014/618976. Epub 2014 Jul 16. PMID: 25165484; PMCID: PMC4140121.

3. Chung JW, Kim WJ, Choi SB, Park JS, Kim DW. Screening for pre-diabetes using support vector machine model. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:2472-5. doi: 10.1109/EMBC.2014.6944123. PMID: 25570491.

4. Choi SB, Park JS, Chung JW, Yoo TK, Kim DW. Multicategory classification of 11 neuromuscular diseases based on microarray data using support vector machine. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:3460-3. doi: 10.1109/EMBC.2014.6944367. PMID: 25570735.

5. Park JS, Choi SB, Chung JW, Kim SW, Kim DW. Classification of serous ovarian tumors based on microarray data using multicategory support vector machines. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:3430-3. doi: 10.1109/EMBC.2014.6944360. PMID: 25570728.

2015

6. Park JS, Chung JW, Kim NK, Cho MS, Kang CM, Choi SB, Kim DW. Exposure of surgeons to extremely low-frequency magnetic fields during laparoscopic and robotic surgeries. Medicine (Baltimore). 2015 Feb;94(6):e539. doi: 10.1097/MD.0000000000000539. PMID: 25674758; PMCID: PMC4602749.

7. Park JS, Choi SB, Rhee Y, Chung JW, Choi EY, Kim DW. Parathyroid hormone, calcium, and sodium bridging between osteoporosis and hypertension in postmenopausal Korean women. Calcif Tissue Int. 2015 May;96(5):417-29. doi: 10.1007/s00223-015-9972-x. Epub 2015 Feb 25. PMID: 25707344.

8. Choi SB, Park JS, Chung JW, Kim SW, Kim DW. Prediction of ATLS hypovolemic shock class in rats using the perfusion index and lactate concentration. Shock. 2015 Apr;43(4):361-8. doi: 10.1097/SHK.0000000000000296. PMID: 25394246.

9. Park JS, Kim DW, Chung JW, Kwon JY, Park YW, Cho HY. Safety of Exposure From Extremely Low Frequency Magnetic Fields During Prenatal Ultrasound Examinations in Clinicians and Pregnant Women. Medicine (Baltimore). 2015 Jul;94(29):e1194. doi: 10.1097/MD.0000000000001194. PMID: 26200630; PMCID: PMC4603025.

10. Park JS, Chung JW, Choi SB, Kim DW, Kim YT, Kim SW, Nam EJ, Cho HY. Exposure of Surgeons to Magnetic Fields during Laparoscopic and Robotic Gynecologic Surgeries. J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1247-51. doi: 10.1016/j.jmig.2015.07.009. Epub 2015 Jul 21. PMID: 26205574.

2016

11. Chung JW, Park JS, Choi SB, Kim DW. Patient exposure to extremely low-frequency magnetic fields during laparoscopic and robotic surgeries. Int J Med Robot. 2016 Sep;12(3):320-5. doi: 10.1002/rcs.1686. Epub 2015 Jul 17. PMID: 26183334.

12. Park JS, Choi SB, Kim HJ, Cho NH, Kim SW, Kim YT, Nam EJ, Chung JW, Kim DW. Intraoperative Diagnosis Support Tool for Serous Ovarian Tumors Based on Microarray Data Using Multicategory Machine Learning. Int J Gynecol Cancer. 2016 Jan;26(1):104-13. doi: 10.1097/IGC.0000000000000566. PMID: 26512784.

13. Park JS, Jung I, Youn JC, Cho HY. Impact of adolescent pregnancy on hypertension in postmenopausal women. J Hypertens. 2016 Jan;34(1):47-53. doi: 10.1097/HJH.0000000000000747. PMID: 26630212.

14. Park JS, Kim DW, Kwon JY, Park YW, Kim YH, Cho HY. Development of a Screening Tool for Predicting Adverse Outcomes of Gestational Diabetes Mellitus: A Retrospective Cohort Study. Medicine (Baltimore). 2016 Jan;95(1):e2204. doi: 10.1097/MD.0000000000002204. PMID: 26735528; PMCID: PMC4706248.

15. Yoo TK, Kim DW, Choi SB, Oh E, Park JS. Simple Scoring System and Artificial Neural Network for Knee Osteoarthritis Risk Prediction: A Cross-Sectional Study. PLoS One. 2016 Feb 9;11(2):e0148724. doi: 10.1371/journal.pone.0148724. PMID: 26859664; PMCID: PMC4747508.

16. Choi SB, Choi JY, Park JS, Kim DW. ATLS Hypovolemic Shock Classification by Prediction of Blood Loss in Rats Using Regression Models. Shock. 2016 Jul;46(1):92-8. doi: 10.1097/SHK.0000000000000574. PMID: 26825636.

2017

17. Kim J, Park JS, Ham WS. The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer. Investig Clin Urol. 2017 Sep;58(5):307-316. doi: 10.4111/icu.2017.58.5.307. Epub 2017 Aug 8. PMID: 28868501; PMCID: PMC5577326.

18. Park JS, Lee KS, Ham WS, Chung BH, Koo KC. Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008. Medicine (Baltimore). 2017 Dec;96(51):e9427. doi: 10.1097/MD.0000000000009427. PMID: 29390570; PMCID: PMC5758272.

2018

19. Park JS, Ha YS, Lee KS, Ahn HK, Ha JS, Ham WS, Chung BH, Koo KC. Impact of metformin on serum prostate-specific antigen levels: data from the national health and nutrition examination survey 2007-2008 PD13-10. The Journal of Urology 199 (4S), e302-e303.

20. Park JW, Jang WS, Koh DH, Lee JS, Ha JS, Park JS, Kim WT, Kim YS, Cho IR, Lee JS, Ham WS, Choi YD. Impact of lymph node metastases on prognosis after radical prostatectomy for patients with oligometastatic prostate cancer. The Journal of Urology 199 (4S), e816-e817.

21. Na JC, Park JS, Yoon MG, Lee HH, Yoon YE, Huh KH, Kim YS, Han WK. Long-term Follow-up of Living Kidney Donors With Chronic Kidney Disease at 1 Year After Nephrectomy. Transplant Proc. 2018 May;50(4):1018-1021. doi: 10.1016/j.transproceed.2018.02.053. PMID: 29731059. 

22. Na JC, Park JS, Yoon MG, Lee HH, Yoon YE, Huh KH, Kim YS, Han WK. Delayed Recovery of Renal Function After Donor Nephrectomy. Transplant Proc. 2018 May;50(4):1022-1024. doi: 10.1016/j.transproceed.2018.01.038. PMID: 29731060.

23. Park JS, Ahn HK, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Development of a Screening Tool to Predict Chronic Kidney Disease Risk in Post-nephrectomy Living Kidney Donors. Transplant Proc. 2018 May;50(4):993-997. doi: 10.1016/j.transproceed.2018.01.034. Epub 2018 Apr 17. PMID: 29678268.

24. Park JS, Ahn HK, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Cumulative sum analysis of the learning curve for video-assisted minilaparotomy donor nephrectomy in healthy kidney donors. Medicine (Baltimore). 2018 Apr;97(17):e0560. doi: 10.1097/MD.0000000000010560. PMID: 29703043; PMCID: PMC5944565.

25. Park JS, Jin MH, Hong CH. Neurologic Mechanisms Underlying Voiding Dysfunction due to Prostatitis in a Rat Model of Nonbacterial Prostatic Inflammation. Int Neurourol J. 2018 Jun;22(2):90-98. doi: 10.5213/inj.1836124.062. Epub 2018 Jun 30. PMID: 29991230; PMCID: PMC6059909.

26. Park JS, Jung HD, Cho YS, Jin MH, Hong CH. Neonatal Bladder Irritation Is Associated With Vanilloid Receptor TRPV1 Expression in Adult Rats. Int Neurourol J. 2018 Sep;22(3):169-176. doi: 10.5213/inj.1836020.101. Epub 2018 Sep 28. PMID: 30286579; PMCID: PMC6177733.

27. Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018 Sep;97(37):e12390. doi: 10.1097/MD.0000000000012390. PMID: 30213007; PMCID: PMC6155960.

28. Park JS, Kim J, Jang WS, Heo JE, Elghiaty A, Rha KH, Choi YD, Ham WS. Management of postoperative ileus after robot-assisted laparoscopic prostatectomy. Medicine (Baltimore). 2018 Nov;97(44):e13036. doi: 10.1097/MD.0000000000013036. PMID: 30383668; PMCID: PMC6221667.

29. Elghiaty A, Kim J, Jang WS, Park JS, Heo JE, Rha KH, Choi YD, Ham WS. Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging. Medicine (Baltimore). 2018 Nov;97(48):e13433. doi: 10.1097/MD.0000000000013433. PMID: 30508956; PMCID: PMC6283223.

2019

30. Park JS, Lee YS, Lee CN, Kim SH, Kim SW, Han SW. Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study. World J Urol. 2019 Aug;37(8):1665-1670. doi: 10.1007/s00345-018-2576-0. Epub 2018 Dec 3. PMID: 30511212.

31. Park JS, Lee YS, Lee CN, Kim SH, Kim SW, Lee H, Han SW. Transurethral incision as initial option in treatment guidelines for ectopic ureteroceles associated with duplex systems. World J Urol. 2019 Oct;37(10):2237-2244. doi: 10.1007/s00345-018-2607-x. Epub 2019 Jan 2. PMID: 30603781.

32. Elghiaty A, Kim J, Jang WS, Park JS, Heo JE, Rha KH, Choi YD, Ham WS. Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging. J Cancer Res Clin Oncol. 2019 Apr;145(4):957-965. doi: 10.1007/s00432-019-02846-x. Epub 2019 Feb 13. PMID: 30758671.

33. Park JS, Lee HJ, Cho NH, Kim J, Jang WS, Heo JE, Ham WS. Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers. Comput Struct Biotechnol J. 2019 Mar 8;17:371-377. doi: 10.1016/j.csbj.2019.03.005. PMID: 30962867; PMCID: PMC6434066.

34. Park JS, Ahn HK, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Cumulative sum analysis of learning curve for video-assisted mini-laparotomy partial nephrectomy in renal cell carcinoma. Medicine (Baltimore). 2019 Apr;98(17):e15367. doi: 10.1097/MD.0000000000015367. PMID: 31027124; PMCID: PMC6831345.

35. Kim J, Park SY, Elghiaty A, Jang WS, Heo JE, Park JS, Choi YD, Ham WS. Is the extirpative surgery for primary tumor helpful for the patients with metastatic urothelial cancer at the time of diagnosis? Medicine (Baltimore). 2019 May;98(22):e15930. doi: 10.1097/MD.0000000000015930. PMID: 31145361; PMCID: PMC6708713.

36. Park JS, Yoon MG, Na JC, Lee HH, Yoon YE, Huh KH, Kim YS, Han WK. Investigation of Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure in Living Kidney Donors After Donor Nephrectomy. Transplant Proc. 2019 Oct;51(8):2533-2538. doi: 10.1016/j.transproceed.2019.03.064. Epub 2019 Aug 27. PMID: 31471015.

37. Park JS, Koo KC, Chung BH, Lee KS. The association of family history of prostate cancer with the diagnosis of clinically significant prostate cancer in Korean population. Investig Clin Urol. 2019 Nov;60(6):442-446. doi: 10.4111/icu.2019.60.6.442. Epub 2019 Sep 5. PMID: 31692911; PMCID: PMC6821985.

38. Park JS, Ham WS, Hong CH, Chung BH, Koo KC. The association of depression with lower urinary tract symptoms: data from the National Health and Nutrition Examination Survey, 2005-2008. PeerJ. 2019 Oct 1;7:e7795. doi: 10.7717/peerj.7795. PMID: 31592197; PMCID: PMC6777489.

39. Park JS, Koo KC, Kim HK, Chung BH, Lee KS. Impact of metabolic syndrome-related factors on the development of benign prostatic hyperplasia and lower urinary tract symptoms in Asian population. Medicine (Baltimore). 2019 Oct;98(42):e17635. doi: 10.1097/MD.0000000000017635. PMID: 31626149; PMCID: PMC6824778.

40. Heo JE, Park JS, Lee JS, Kim J, Jang WS, Rha KH, Choi YD, Hong SJ, Ham WS. Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy. Medicine (Baltimore). 2019 Oct;98(42):e17627. doi: 10.1097/MD.0000000000017627. PMID: 31626145; PMCID: PMC6824791.

41. Park JS, Koo KC, Choi IY, Lee JY, Hong JH, Kim CS, Lee HM, Hong SK, Byun SS, Rha KH, Chung BH, Lee KS. Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis. Medicine (Baltimore). 2019 Nov;98(45):e17931. doi: 10.1097/MD.0000000000017931. PMID: 31702677; PMCID: PMC6855645.

42. Kim J, Park JS, Heo JE, Elghiaty A, Jang WS, Rha KH, Choi YD, Ham WS. Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion. Yonsei Med J. 2019 Nov;60(11):1021-1027. doi: 10.3349/ymj.2019.60.11.1021. PMID: 31637883; PMCID: PMC6813139.

43. Park JS, Koo KC, Chung BH, Lee KS. Is targeted biopsy really needed when performing systematic prostate biopsy to raise the detection rate for prostate cancer in patients with prostate-specific antigen ≤10 ng/mL? Medicine (Baltimore). 2019 Dec;98(51):e18505. doi: 10.1097/MD.0000000000018505. PMID: 31861036; PMCID: PMC6940157.

2020

44. Park JS, Lee D, Koo KC, Chung BH, Lee KS. The role of prostatic apex shape in voiding symptoms and urine flow: an exploratory and confirmatory study. World J Urol. 2020. May;38(5):1275-1282. doi: 10.1007/s00345-019-02925-1. Epub 2019 Aug 27. PMID: 31456018

45. Heo JE, Park JS, Lee JS, Kim J, Jang WS, Cho NH, Rha KH, Choi YD, Hong SJ, Ham WS. Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients. J Cancer Res Clin Oncol. 2020 Jan;146(1):221-227. doi: 10.1007/s00432-019-03049-0. Epub 2019 Oct 14. PMID: 31612318.

46. Park JS, Jang WS, Hong SJ, Choi YD, Rha KH, Ham WS. Association between prostate cancer and 25-hydroxyvitamin D2 levels: National Health and Nutrition Examination Survey 2007-2008 results. The Korean Journal of Urological Oncology. 2020, 18(1). 32-39.

47. Park JS, Pierorazio PM, Lee JH, Lee HJ, Lim YS, Jang WS, Kim J, Lee SH, Rha KH, Cho NH, Ham WS. Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers. Cancers (Basel). 2020 Jan 16;12(1):222. doi: 10.3390/cancers12010222. PMID: 31963294; PMCID: PMC7017065.

48. Park JS, Lee HJ, Almujalhem A, Althubiany HH, A AA, Jang WS, Kim J, Lee SH, Rha KH, Ham WS. Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients with Localized Pathologic T1N0M0 Stage Disease. Cancers (Basel). 2020 May 7;12(5):1182. doi: 10.3390/cancers12051182. PMID: 32392781; PMCID: PMC7281002.

49. Lee J, Park JS, Heo JE, Ahn HK, Jang WS, Ham WS, Rha KH, Choi YD. Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer. Cancers (Basel). 2020 Jul 10;12(7):1864. doi: 10.3390/cancers12071864. PMID: 32664444; PMCID: PMC7408770.

50. Park JS, Koo KC, Chung DY, Kim SI, Kim J, Oh CK, Kim TN, Kang SK, Park JW, Yoon YE, Park SY, Rha KH, Ham WS. Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2020 Dec 2;12(12):3602. doi: 10.3390/cancers12123602. PMID: 33276522; PMCID: PMC7761595.

2021

51. Park JS, Jang WS, Kim J, Lee SH, Rha KH, Ham WS. Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial. Cancer Metab. 2021 Apr 6;9(1):15. doi: 10.1186/s40170-021-00251-y. PMID: 33823929; PMCID: PMC8025550.

52. Park JS, Lee ME, Kim SH, Jang WS, Ham WS. Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model. Biol Open. 2021 Apr 15;10(4):bio058566. doi: 10.1242/bio.058566. Epub 2021 Apr 20. PMID: 33913471; PMCID: PMC8084570.

53. Lee SH, Park JS (co-first author), Kim H, Kim D, Lee SH, Ham WS, Han WK, Choi YD, Yun M. Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging. Cancers (Basel). 2021 May 14;13(10):2381. doi: 10.3390/cancers13102381. PMID: 34069168; PMCID: PMC8155930.

54. Park JS, Lee ME, Jang WS, Rha KH, Lee SH, Lee J, Ham WS. The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity. Cancers (Basel). 2021 May 24;13(11):2574. doi: 10.3390/cancers13112574. PMID: 34073906; PMCID: PMC8197413.

55. Ham WS, Park JS, Jang WS, Choi YD, Kim J. Prognostic value of prostate volume in non-muscle invasive bladder cancer. Sci Rep. 2021 Sep 22;11(1):18784. doi: 10.1038/s41598-021-98045-1. PMID: 34552102; PMCID: PMC8458356.

56. Park JS, Kim DW, Lee D, Lee T, Koo KC, Han WK, Chung BH, Lee KS. Development of prediction models of spontaneous ureteral stone passage through machine learning: Comparison with conventional statistical analysis. PLoS One. 2021 Dec 1;16(12):e0260517. doi: 10.1371/journal.pone.0260517. PMID: 34851999; PMCID: PMC8635399.

57. Kim D, Lee N, Lee SH, Kim HJ, Hong HS, Park JS, Cho NH, Choi YD, Ham WS, Lee SH, Han WK, Yun M. Metabolic tumour volume on 18F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging. Sci Rep. 2021 Dec 6;11(1):23486. doi: 10.1038/s41598-021-03023-2. PMID: 34873277; PMCID: PMC8648871.

2022

58. Park JS, Lee ME, Jang WS, Kim J, Park SM, Oh K, Lee N, Ham WS. Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment. Biomedicines. 2022 Jan 14;10(1):173. doi: 10.3390/biomedicines10010173. PMID: 35052851.

59. Park JS, Lee ME, Jang WS, Kim J, Park SM, Ham WS. Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers. Biomedicines. 2022 Jan 29;10(2):321. doi: 10.3390/biomedicines10020321. PMID: 35203530; PMCID: PMC8869331.

60. Park JS, Ham WS, Lee ME, Jang WS, Oh K, Lee N. 34P Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model. Ann Oncol. 2022, 33, S557.

61. Ham WS, Park JS, Lee ME, Jang WS, Oh K, Lee N. 38P Development of therapeutic biomarkers for oncolytic vaccinia virus using cell-line derived xenograft mouse model. Ann Oncol. 2022, 33, S558. 

62. Ham WS, Park JS, Jang WS, Kim J. Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies. Biomedicines, 2022 Sep 8;10(9):2223. doi: 10.3390/biomedicines10092223. PMID: 36140325; PMCID: PMC9496458.

2023

63. Park JS, Lee ME, Jang WS, Kim J, Lee N, Oh K, Ham WS. Anti-PD1 plus oncolytic virus as first-line treatment option for metastatic renal cell carcinomas. J Clin Oncol. 2023 41:6_suppl, 675.

64. Park JS, Lee ME, Jang WS, Kim J, Lee N, Oh K, Ham WS. Predictive biomarkers for the oncolytic virus, JX-594, through the HIF-dependent interferon beta pathway in metastatic renal cell carcinoma. J Clin Oncol. 2023 41:6_suppl, 710.

65. Kim H, Park JS (co-first author), Choi Z, Min S, Park J, Shin S, Choi JR, Lee ST, Ham WS. Exploring the Characteristics of Circulating Tumor DNA in Pt1a Clear Cell Renal Cell Carcinoma: A Pilot Study. Cancers (Basel). 2023 Jun 23;15(13):3306. doi: 10.3390/cancers15133306. PMID: 37444416; PMCID: PMC10341247.

66. Jo Y, Kim JS, Shin YS, Kim J, Jang WS, Park JS (co-corresponding author), Ham WS. Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis. Journal of Urologic Oncology 2023;21(2):165-173.

2024

67. Park JS, Kim J, Jeon J, Lee J, Jang WS, Lee SH, Han WK, Choi YD, Koo KC, Cho KS, Chung BH, and Ham WS. The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): A study protocol for a multi-center, prospective, randomized trial. J Clin Oncol. 2024 42:4_suppl, TPS490-TPS490.

68. Park JS, Lee ME, Jang WS, Kim J, Shin G, Ham WS. Association between β3-adrenergic receptor agonist use and risk of kidney cancer among patients with overactive bladder. J Clin Oncol. 2024 42:4_suppl, 456.

69. Park JS, Lee ME, Jang WS, Kim J, Shin G, Ham WS. Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic renal cell carcinoma by decreasing IL-6 to modulate tumor-associated macrophage and myeloid-derived suppressor cell. J Clin Oncol. 2024 42:4_suppl, 457.

70. Park JS, Lee ME, Kim J, Oh K, Lee N, Jung M, Jang WS, Ham WS. PD-1 inhibitor plus oncolytic vaccinia virus is a safe and effective treatment option for metastatic renal cell carcinoma. Cancer Cell Int. 2024 Jan 30;24(1):50. doi: 10.1186/s12935-024-03238-z. PMID: 38291394; PMCID: PMC10829278.

71. Park JS, Choi SB, Jang WS, Kim J, Ham WS. Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study. Eur Urol Focus. 2024 Feb 21:S2405-4569(24)00019-1. doi: 10.1016/j.euf.2024.02.002. Epub ahead of print. PMID: 38388215.

72. Park JS (co-first author), Kim H, Jang WS, Kim J, Ham WS (co-corresponding author), Lee ST. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy. Cancer Sci. 2024 Mar 12. doi: 10.1111/cas.16146. Epub ahead of print. PMID: 38475661.

73. Ham WS, Park JS, Jang WS, Kim J. Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer. Front Oncol. 2024 Mar 

13;14:1368926. doi: 10.3389/fonc.2024.1368926. PMID: 38544836; PMCID: PMC10965631.

74. Kim J, Ham WS, Park JS, Jang WS. Incidence and pattern of recurrence after surgical resection in organ confined renal cell carcinoma. Yonsei Med J. 2024 Jul;65:e51. doi.org/10.3349/ymj.2023.0587.

75. Park JS, Lee J, Lee ME, Kim J, Jang WS, Lee JJ, Lee JS, Kang M, Ham WS. The potential anti-cancer activity of dual TTK/PLK1 inhibitor, BAL0891, in bladder cancer. Cancer Res. 2024 84:6_suppl, 5726.

76. Park JS, Kim J, Jeon J, Lee J, Jang WS, Lee SH, Han WK, Choi YD, Koo KC, Cho KS, Chung BH, Ham WS. The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): study protocol for a multi-center, prospective, randomized trial. Trials. 2024 Jul 3;25(1):447. doi: 10.1186/s13063-024-08234-2. PMID: 38961439; PMCID: PMC11223430.

77. Park JS, Jang WS, Kim J, Park M, Ham WS. Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder. Investigative and Clinical Urology, 2024, 66.

78. Park JS, Kim EC, Song S, Kim J, Jang WS, Hwang B, Ham WS, Single cell RNA sequencing to reveal genetic biomarkers and immune microenvironment of patients with aggressive small renal cell carcinoma. JCO 42, e16517-e16517 (2024).

79. Park JS, Kim EC, Lee ME, et al. 176 Immunological impact of cytoreductive nephrectomy in combination with immune checkpoint inhibitors in metastatic renal cell carcinoma: insights from the SEVURO-CN trial Journal for ImmunoTherapy of Cancer 2024;12:doi: 10.1136/jitc-2024-SITC2024.0176.

80. Ham WS, Park JS, Jang WS, Kim J. Role of Maximal Transurethral Resection Preceding Partial Cystectomy for Muscle-Invasive Bladder Cancer. Ann Surg Oncol. 2024 Feb;31(2):1384-1392. doi: 10.1245/s10434-023-14449-5.

2025

81. Park JS, Kim EC, Song S, Kim J, Jang WS, Hwang B, Ham WS. Identification of potential immune evasion mechanisms in aggressive small renal cell carcinomas through single-cell and bulk RNA sequencing. JCO 43, 574-574(2025). DOI:10.1200/JCO.2025.43.5_suppl.574.

82. Park JS, Choi SB, Kim J, Jang WS, Ham WS. Impact of β3-adrenergic receptor agonist on kidney cancer risk in patients with overactive bladder. BJU Int. 2025 May 9. doi: 10.1111/bju.16771. Epub ahead of print. PMID: 40344609.

83.  Park JS, Jang WS, Heo J, Ham WS, Kim KH, Nam JK, Lim BJ, Hong BS, Nam W, Lee S, Oh JJ, Jeong SH, Ku JH, Noh TI, Kang SG, Kang SH, Ha YS, Kwon TG, Kim TH, Kim J, Song G, Seo HK, Song W, Sung HH, Jeong BC. Gender and menopause impact on recurrence and cancer-specific mortality in bladder cancer after radical cystectomy: a retrospective cohort study. J Urol Oncol. 2025;23(1):88–93. doi:10.22465/juo.255000140007

84. Park JS, Lee ME, Jung M, Kim J, Jang WS, Ham WS. Impact of β3-adrenergic receptor agonist on tumor progression and metastasis in renal cell carcinoma models. Cancer Cell Int. 2025 Jun 11;25(1):209. doi: 10.1186/s12935-025-03834-7. PMID: 40500705; PMCID: PMC12153155.

1. 소음 검출 방법 및 소음 검출 시스템 (A method and system for analyzing noise) 

• 출원번호 : 1020100097755 

• 등록번호 : 101123880 

2. 암의 진단을 위한 정보를 제공하는 방법 (A method of providing information for diagnosing cancer)

• 출원번호 : 1020180163080

• 등록번호 : 102164052

3. 수분 섭취량 예측 시스템 (System for predicting water intake)

• 출원번호 : 1020220045752

• 등록번호 : 102772188

• Byung Ha Chung and Prostate Cancer Working Group. Guide to surviving prostate cancer (2nd edition). Health Chosun, 2019. (전립선암 완치 설명서)

• Receptor Tyrosine Kinase c-MET: A Biomarker and Therapeutic Target in Cancer. In A. Sabarwal, S. Tabasum, & S. Pal (Eds.), Receptor Tyrosine Kinases in Cance. Springer. 2025. https://doi.org/10.1007/978-3-031-93894-8_9     

International conferences

-      Kim SK, Yoo TK, Park JS, Kim DW. Risk Prediction of Osteoporosis at Any Site among Total Hip, Femoral Neck, or Lumbar Spine Using Machine Learning and Conventional Methods, Asian Federation of Osteoporosis Societies, Seoul, Korea, (Sep 6-8), 2013. (oral)

-      Choi SB, Park JS, Chung JW, Yoo TK, Kim DW. Multicategory classification of 11 neuromuscular diseases based on microarray data using support vector machine, 36th IEEE Engineering in Medicine and Biology Society, Chicago, USA, (August 26-30), 2014. (oral)

-      Park JS, Choi SB, Chung JW, Kim SW, Kim DW. Classification of serous ovarian tumors based on microarray data using multicategory support vector machines, 36th IEEE Engineering in Medicine and Biology Society, Chicago, USA, (August 26-30), 2014 (oral)      

-      Chung JW, Kim WJ, Choi SB, Park JS, Kim DW. Screening for pre-diabetes using support vector machine model, 36th IEEE Engineering in Medicine and Biology Society, Chicago, USA, (August 26-30), 2014 (oral)             

-      Kim DW, Cho M, Kim NK, Chung JW, Park JS, Choi SB. Intensity of magnetic fields exposed to surgeons and patients during laparoscopic and robotic surgeries for low anterior resection, Society of Robotic Surgery, Orlando, Florida, (Feb. 19-22), 2015 (poster)  

-      Park JS, Choi SB, Chung JW, Kim DW. Relationship between osteoporosis and hypertension with low calcium and high sodium dietary intake in Korean population (KHANES IV-V, 2008-2011), 4th Joint Meeting of European Calcified Tissue Society and the International Bone and Mineral Society (IBMS), Rotterdam, Netherlands, (April 25-28), 2015 (poster)        

-      Park JS, Choi SB, Rhee Y, Chung JW, Choi E, Kim DW. Parathyroid hormone, calcium, and sodium bridging between osteoporosis and hypertension in postmenopausal Korean women, 2015 Seoul International Congress of Endocrinology and Metabolism, Seoul, Korea, (April 30 - May 3), 2015 (oral)          

-      Park JS, Chung JW, Choi SB, Kim DW, Kim YT, Kim SW, Nam EJ, Cho HY. How much are surgeons and patients exposed to 60 Hz magnetic fields during laparoscopic and robotic gynecologic surgeries?, 24th Asian & Oceanic Congress of Obstetrics & Gynaecology (AOCOG), Kuching, Malaysia, (June 4-6), 2015 (oral)               

-      Choi SB, Kim SW, Chung JW, Park JS, Noh HW, Kim DW. New adaptive algorithm to determine sleep onset latency, 37th IEEE Engineering in Medicine and Biology Society, Milan, Italy, (August 25-29), 2015 (oral)

-      Park JS, Ahn HK, Kim J, Kang SK, Oh KT, Kim JW, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Development of a screening tool for predicting chronic kidney disease after donor nephrectomy in living donors, Asian Transplantation Week 2017, Incheon, Korea, (October 18-22), 2017 (oral)

-      Park JS, Ahn HK, Kim J, Kang SK, Oh KT, Kim JW, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Cumulative Sum Analysis of the Learning Curve for Video-Assisted Minilaparotomy Donor Nephrectomy in Healthy Kidney Donors, Asian Transplantation Week 2017, Incheon, Korea, (October 18-22), 2017 (oral)

-      Park JS, Ha YS, Lee KS, Ahn HK, Ha JS, Ham WS, Chung BH, Koo KC. Impact of metformin on serum prostate-specific antigen levels: data form the national health and nutrition examination survey 2007-2008, American Urological Association, San Francisco, (May 18-21), 2018 (podium)

-      Park JW, Jang WS, Koh DH, Lee JS, Ha JS, Park JS. Impact of lymph node metastases on prognosis after radical prostatectomy for patients with oligometastatic prostate cancer, American Urological Association, San Francisco, (May 18-21), 2018 (podium)

-      Son HS, Moon SY, Ahn HK, Oh KT, Park JS, Ha JS, Kim JH. The effect of beta-3 adrenergic receptor agonist on micromotions of major pelvic ganglion disconnected rat bladder, American Urological Association, San Francisco, (May 18-21), 2018 (moderated poster)

-      Koo KC, Lee JS, Park JS, Ha YS, Ahn HK, Lee KS, Ha JS, Kim DJ, Oh KT, Rha KH, Hong SJ, Chung BH. Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio, American Urological Association, San Francisco, (May 18-21), 2018 (moderated poster)

-      Lee JS, Park JS, Ha YS, Lee KS, Ahn HK, Ha JS, Kim DK, Lee DH, Rha KH, Hong SJ, Chung BH, Koo KC. Subcutaneous fat distribution is a prognostic biomarker for men with castration-resistant prostate cancer, American Urological Association, San Francisco, (May 18-21), 2018 (moderated poster)

-      Park JS, Ham WS, Hong CH, Chung BH, Koo KC. The Association of Depression and Lower Urinary Tract Symptoms, 38th Congress of the Société Internationale d'Urologie, Seoul, (Oct 4-7), 2018 (moderated poster)

-      Park JS, Kim JC, Jang WS, Heo JE, Elghiaty A, Rha KH, Choi YD, Ham WS. Management of Postoperative Ileus after Robot-Assisted Laparoscopic Prostatectomy, 38th Congress of the Société Internationale d'Urologie, Seoul, (Oct 4-7), 2018 (moderated poster)

-      Park JS, Ahn HK, Kang SK, Oh KT, Na J, Lee HH, Yoon YE, Yoon MG, Han WK. Prediction of Chronic Kidney Disease Risk in Patients with Partial Nephrectomy, 38th Congress of the Société Internationale d'Urologie, Seoul, (Oct 4-7), 2018 (moderated poster)

-      Park JS, Yoon MG, Na J, Lee HH, Yoon YE, Huh KH, Kim MS, Kim SI, Kim YS, Han WK. Prediction model of chronic kidney disease after donor nephrectomy in living kidney donors of postmenopausal women, Asian Transplantation Week 2018, Busan, Korea, (November 8-10), 2018 (poster-oral)

-      Park JS, Yoon MG, Na J, Lee HH, Yoon YE, Huh KH, Kim MS, Kim SI, Kim YS, Han WK. Investigation of pulse pressure, systolic blood pressure, and diastolic blood pressure in living kidney donors after donor nephrectomy, Asian Transplantation Week 2018, Busan, Korea, (November 8-10), 2018 (oral)

-      Park JS, Yoon MG, Na J, Lee HH, Yoon YE, Huh KH, Kim MS, Kim SI, Kim YS, Han WK. Investigations of living donor nephrectomy on mineral metabolism in postmenopausal Asian women, Asian Transplantation Week 2018, Busan, Korea, (November 8-10), 2018 (oral)

-      Park JS, Lee KS, Koo KC, Chung BH. The role of prostatic apex shape in voiding symptom and urine flow: A development and validation study, The 34th Annual European Association of Urology (EAU) Congress, 15-19, March 2019, Barcelona, Spain

-      Park JS, Lee KS, Koo KC, Chung BH. Implementation of grayscale values of hypoechoic lesions in transrectal ultrasound-guided biopsy for predicting prostate cancer and clinically significant prostate cancer: A validating confirmatory study, The 34th Annual European Association of Urology (EAU) Congress, 15-19, March 2019, Barcelona, Spain (oral)

-      Park JS, Lee KS, Koo KC, Chung BH. Usefulness of numerical imaging analysis for distinguishing pathologic features in small renal masses: A development and validation study, The 34th Annual European Association of Urology (EAU) Congress, 15-19, March 2019, Barcelona, Spain (oral)

-      Park JS, Yoon MG, Na J, Lee HH, Yoon YE, Huh KH, Kim MS, Kim SI, Kim YS, Han WK. Assessment of delta-neutrophil index in living kidney donors: toward understanding the pathogenesis of renal function recovery, Asian Transplantation Week 2019, Gyeongju, Korea, (October 17-19), 2019 (poster-oral)

-      Park JS, Ham WS, Lee ME, Jang WS, Oh K, Lee N. Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model, ESMO Congress 2022, Paris, France, 9-13 September 2022 (poster).

-      Ham WS, Park JS, Lee ME, Jang WS, Oh K, Lee N. Development of therapeutic biomarkers for oncolytic vaccinia virus using cell-line derived xenograft mouse model, ESMO Congress 2022, Paris, France, 9-13 September 2022 (poster).

-      Park JS, Lee ME, Jang WS, Kim J, Lee N, Oh K, Ham WS. Anti-PD1 plus oncolytic virus as first-line treatment option for metastatic renal cell carcinomas, ASCO GU 2023, San Francisco, CA, 16-18 February 2023 (poster).

-      Park JS, Lee ME, Jang WS, Kim J, Lee N, Oh K, Ham WS. Predictive biomarkers for the oncolytic virus, JX-594, through the HIF-dependent interferon beta pathway in metastatic renal cell carcinoma, ASCO GU 2023, San Francisco, CA, 16-18 February 2023 (poster).

-      Park JS, Lee ME, Jang WS, Kim J, Park SM, Ham WS. The role of cytoreductive nephrectomy in perspectives of tumor immune microenvironment, European Association of Urology (EAU) Congress 2023, 10-13, March 2023, Milan, Italy (oral)

-      Park JS, Lee J, Jang WS, Kim J, Ham WS. The potential of fibrinogens to differentiate between complex renal cysts and cystic renal cell carcinomas in small renal masses, European Association of Urology (EAU) Congress 2023, 10-13, March 2023, Milan, Italy (oral)

-      Park JS, Lee ME, Jang WS, Kim J, Park SM, Ham WS. The role of cytoreductive nephrectomy with immune checkpoint inhibitor therapies in metastatic renal cell carcinoma murine model, American Urological Association (AUA) 2023, Chicago, Apr 28-May 1, 2023 (podium)

-      Park JS, Lee ME, Jang WS, Kim J, Park SM, Ham WS. Sequential usage of mTOR inhibitor followed by immunotherapies for cabozantinib-resistant metastatic clear cell renal cell carcinomas, American Urological Association (AUA) 2023, Chicago, Apr 28-May 1, 2023 (podium)

-      Park JS, Lee J, Jang WS, Kim J, Ham WS. The association between cystic components and fibrinogens in small renal masses, American Urological Association (AUA) 2023, Chicago, Apr 28-May 1, 2023 (moderated poster) 

-         Park JS, Lee ME, Jang WS, Kim J, Ham WS. Single-cell RNA sequencing of BCG-unresponsive Non–Muscle Invasive Bladder Cancer, The 2nd Annual Meeting of KUOS-EAUOS, Incheon, Sep 15-16, 2023 (podium)

-      Park JS, Lee ME, Jang WS, Kim J, Ham WS. The role of cytoreductive nephrectomy for metastatic renal cell carcinoma in immune checkpoint inhibitor settings, Urological Association of Asia (UAA) Congress, Dubai, UAE, Sep 28-Oct 1, 2023 (oral)

-      Park JS. Investigation on genomics of aggressive clear cell renal cell carcinoma, Asia Pacific Society of Clinical Genomics, Seoul, Jan 20, 2024 (oral)

-      Park JS, Kim J, Jeon J, Lee J, Jang WS, Lee SH, Han WK, Choi YD, Koo KC, Cho KS, Chung BH, and Ham WS. The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): A study protocol for a multi-center, prospective, randomized trial. ASCO GU 2024, San Francisco, CA, 25-27 January 2024 (poster)

-      Park JS, Lee ME, Jang WS, Kim J, Shin G, Ham WS. Association between β3-adrenergic receptor agonist use and risk of kidney cancer among patients with overactive bladder. ASCO GU 2024, San Francisco, CA, 25-27 January 2024 (poster)

-      Park JS, Lee ME, Jang WS, Kim J, Shin G, Ham WS. Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic renal cell carcinoma by decreasing IL-6 to modulate tumor-associated macrophage and myeloid-derived suppressor cell. ASCO GU 2024, San Francisco, CA, 25-27 January 2024 (poster)

-        Park JS, Lee J, Lee ME, Kim J, Jang WS, Lee JJ, Lee JS, Kang M, Ham WS. The potential anti-cancer activity of dual TTK/PLK1 inhibitor, BAL0891, in bladder cancer. AACR 2024, San Diego, CA, 5-10 April 2024 (poster)

-        Park JS, Seok JE, Kim J, Jang WS, Lee SH, Han WK, Choi YD, Ham WS. Impact of Tumor Regression Following Neoadjuvant Androgen Deprivation Therapy on Oncological Outcomes in Localized Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy, The 3rd Annual Meeting of KUOS-EAUOS, Seoul, Sep 27-28, 2024 (podium)

-        Park JS, Kim J, Seok JE, Jang WS, Heo J, Kim KH, Nam JK, Lim BJ, Hong BS, Nam W, Oh JJ, Jeong SH, Ku JH, No TI, Kang SH, Ha YS, Song G, Seo HK, Song W, Sung HH, Jeong BC, Choi J, Ham WS. Influence of Gender and Menopausal Status on Recurrence and Prognosis of Bladder Cancer Following Radical Cystectomy: Results from the Korean Bladder Cancer Study Group Database, The 3rd Annual Meeting of KUOS-EAUOS, Seoul, Sep 27-28, 2024 (podium)

-      Park JS, Kim EC, Lee ME, Song S, Kim J, Jang WS, Hwang B, Ham WS. Immunological impact of cytoreductive nephrectomy in combination with immune checkpoint inhibitors in metastatic renal cell carcinoma: insights from the SEVURO-CN trial. SITC 2024, Houston, TX, 6-10 November 2024 (poster)

-        Park JS, Kim EC, Song S, Kim J, Jang WS, Hwang B, Ham WS. Identification of potential immune evasion mechanisms in aggressive small renal cell carcinomas through single-cell and bulk RNA sequencing. ASCO GU 2025, San Francisco, CA, 13-15 February 2025 (poster)

-        Park JS, Kim J, Jang WS, Ham WS. Metabolic Biomarkers Identify High-Risk Recurrence After Robot-Assisted Laparoscopic Partial Nephrectomy in Clear Cell Renal Cell Carcinoma. KSER 2025, Seoul, 10-13 July 2025 (oral)

Domestic conferences

-      박지수, 최수범, 김성권, 유태근, 김덕원. Diagnosis of neuromuscular diseases using multicategory classification, 대한신경과학회 추계학술대회(KNA'13), 서울, 11월 1일, 2013

-      정재원, 김성권, 최수범, 박지수, 김덕원. 저주파 대역의 전자기장이 인공 심장 박동기 및 제세동기에 미치는 영향, 대한의용생체공학회 추계학술대회(KOSOMBE'13), 인천, 11월 8일, 2013

-      정재원, 김성권, 최수범, 박지수, 김덕원. 마이크로파 전자파가 인공 심장 박동기 및 이식형 제세동기에 미치는 영향, 대한의용생체공학회 추계학술대회(KOSOMBE'13), 인천, 11월 8일, 2013

-      박지수, 최수범, 유태근, 정재원, 김덕원. Classification of serous borderline ovarian tumors based on microarray data using multicategory machine learning, 대한부인종양학회 춘계학술대회, 대구, 4월 2일, 2014

-      정재원, 최수범, 유태근, 박지수, 김덕원. SVM 모델을 이용한 전당뇨병 감별, 대한의용생체공학회 춘계학술대회(KOSOMBE'14), 오송, 5월 9일, 2014

-      최수범, 박지수, 유태근, 정재원, 김덕원. SVM을 이용한 마이크로 어레이 데이터 기반의 11개의 신경 근육병증 다중분류, 대한의용생체공학회 춘계학술대회(KOSOMBE'14), 오송, 5월 9일, 2014

-      박지수, 장원식, 이주용, 김종찬, 최영득 함원식. 임상적 저위험군 전립선암환자에서의 장기 사망률에 대한 근치적 전립선적출술의 불량한 병리 소견 및 글리슨 점수 등급 상승의 영향, 대한비뇨기과학회 통합학술대회, ICC 제주, 4월 14-15일, 2017 (포스터)

-      손희서, 이종수, 강숭구, 김종원, 박지수, 하지수, 김장환. Effectiveness of female readjustable sling system for patients with detrusor underactivity, 대한비뇨기과학회 통합학술대회, ICC 제주, 4월 14-15일, 2017 (포스터)

-      박지수, 김상운, 이용승, 한상원. 인공 괄약근 제거와 동시에 시행한 방광목 슬링 수술의 경험, 대한소아비뇨기과학회 추계학술대회 (증례토론회), 전북대학교 의학전문대학원, 9월 2일, 2017 (구연)

-      박지수, 안현규, 김진우, 강숭구, 오경택, 김종원, 나준채, 이형호, 윤영은, 윤민지, 한웅규, 생체 신공여자의 신 적출술 후 만성 신장질환 위험 예측 모델, 제 69차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 9월 27-29일, 2017 (구연)

-      박지수, 이형호, 허지은, 최영득, 나군호, 이주용, 함원식. 전립선암 과거력과 25(OH)D2 수치와의 상관관계: 미국 국가 보건영양실태조사 (NHANES) 2007-2008, 제 69차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 9월 27-29일, 2017 (구연)

-      박지수, 이광석, 함원식, 정병하, 구교철. Impact of metformin on serum prostate-specific antigen levels: data from the National Health and Nutrition Examination Survey (NHANES) 2007-2008, 제 69차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 9월 27-29일, 2017 (구연)

-      박지수, 안현규, 김진우, 강숭구, 오경택, 김종원, 나준채, 이형호, 윤영은, 윤민지, 한웅규, 신장암 환자의 부분 신 절제술 후 만성 신장질환 위험 예측 모델, 제 69차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 9월 27-29일, 2017 (포스터)

-      박지수, 안현규, 김진우, 강숭구, 오경택, 김종원, 나준채, 이형호, 윤영은, 윤민지, 한웅규, 누적합법을 통해 영상보조 최소절개술을 이용한 부분 신장절제술의 학습곡선 분석, 제 69차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 9월 27-29일, 2017 (포스터)

-      박지수, 이초녕, 이용승, 김상운 한상원, 중복요관 이소성 요관류 소아환자에서 내시경적 요관류 절개술의 임상적 가치, 제 31차 대한소아비뇨기과학회 정기학술대회, 서울성모병원, 4월 7일, 2018 (구연)

-      박지수, 안현규, 김진우, 강숭구, 오경택, 김종원, 나준채, 이형호, 윤영은, 윤민지, 한웅규, 누적합법을 통해 영상보조 최소절개술을 이용한 부분 신장절제술의 학습곡선 분석, 제 25차 대한ENDOUROLOGY 학술대회, 신촌세브란스병원, 6월 14-15일, 2018 (구연)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 나군호, 최영득, 홍성준, 한웅규, 저병기 전립선암 진단 후 호르몬 단독 치료만 시행한 군에 대한 보고, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 허규하, 김명수, 김순일, 김유선, 나군호, 최영득, 홍성준, 한웅규, 폐경기 아시아 여성에 있어 생체 신공여자의 신 적출술 후 미네랄 대사의 변화에 대한 분석, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 허규하, 김명수, 김순일, 김유선, 나군호, 최영득, 홍성준, 한웅규, 생체 신공여자의 신 적출술 후 맥암, 수축기 혈압, 이완기 혈압 변화 경향 분석, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      박지수, 함원식, 홍창희, 나군호, 정병하, 최영득, 구교철, 우울증이 하부 요로 증상에 미치는 영향: 미국 국가 보건영양실태조사 (NHANES) 2005-2008 데이터, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      박지수, 전진형, 김종찬, 아흐메드아바스 알사이비, 함원식, 고환암 발병률 및 사망률의 최근 전세계 경향, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      허지은, 박지수, 이종수, 김종찬, 장원식, 나군호, 최영득, 홍성준, 함원식, Gleason score versus T stage after radical prostatectomy: which is more important? 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      허지은, 김진우, 박지수, 이종수, 김종찬, 장원식, 나군호, 최영득, 홍성준, 함원식, Biochemical recurrence outcome following radical prostatectomy in patients with extraprostatic extension in contemporary Gleason score 6 prostate cancer, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (구연)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 나군호, 최영득, 홍성준, 한웅규, 전이가 없는 고병기 전립선암 환자에 있어 치료 패턴 및 결과 분석, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (포스터)

-      김종찬, Ahmed Elghiaty, 장원식, 허지은, 박지수, 최영득, 함원식, 고위험 전립선암 환자에서 골반림프절 절제술의 종양학적 결과: 성향 점수 매치 분석, 제 70차 대한비뇨기과학회 추계학술대회, 서울 The-K 호텔, 11월 28-30일, 2018 (포스터)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 허규하, 김명수, 김순일, 김유선, 한웅규, 신장공여자에서의 delta-neutrophil index 평가를 통해 신장 기능 회복 기전에 대한 이해, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 이효정, 임영선, 김종찬, 장원식, 이승환, 나군호, 최영득, 조남훈, 이지현, Ahmad Almujalhem, Hatem Hamed Althubiany, Aalqahtani Ali A, 함원식, 임상적 T1 병기의 투명신세포암 환자 중 공격적 성향을 보이는 환자군에서의 유전자적 특징 분석, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 함원식, 한웅규, 나군호, 최영득, 김동우, 윤미진, 조남훈, 이승환, 전이성 신장암 환자에서의 수술 전 C-11 Methionine 양전자 방출 단층 촬영의 효용성, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, 임상적으로 의미 있는 전립선 암의 진단에 있어 전립선 초음파에서 저에코 병변의 그레이 스케일 값의 효용성, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, 기계 학습을 이용하여 요관 결석의 자연 확률 예측 모델 개발, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, 배뇨 증상 및 요 흐름에서의 전립선 출구부의 역할, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, PSA 10 ng/mL 이하인 환자에서 표적 전립선 조직 검사가 진짜 필요할까?, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (구연)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, 한국인에서의 가족력과 임상적으로 의미 있는 전립선암 진단과의 연관성 분석, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (포스터)

-      박지수, 구교철, 한웅규, 홍창희, 나군호, 최영득, 정병하, 이광석, 임상/병리학적 특징에 기반하여 근치적 전립선 절제술을 시행한 환자에서의 생존율 구분, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (포스터)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 허규하, 김명수, 김순일, 김유선, 한웅규,폐경 후 여성 생체 신공여자의 신 적출술 후 만성 신장질환 위험 예측 모델, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (포스터)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 한웅규, 전이가 없는 고병기 전립선암의 근치적 전립선 절제술 후 방사선 및 호르몬 병용 치료 후 생화학적 재발 예측, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (포스터)

-      박지수, 윤민지, 나준채, 이형호, 윤영은, 한웅규, 호르몬 단독 치료를 시행한 임상적으로 국한된 전립선 암에 있어 PSA nadir와 암 진행과의 연관성, 제 71차 대한비뇨의학회 추계학술대회, 서울 COEX, 10월 30일-11월 2일, 2019 (포스터)

-      박지수, 이명은, 장원식, 김종찬, 이승환, 나군호, 함원식, 폐전이 신세포암 마우스 모델의 개발, 제 72차 대한비뇨의학회 추계학술대회, 10월 15일-10월 16일, 2020 (온라인 포스터)

-      박지수, 이명은, 장원식, 김종찬, 이승환, 나군호, 함원식, 진행성 투명세포 신세포암의 바이오 마커, DEAD/DEAH box helicase, DDX11, 제 72차 대한비뇨의학회 추계학술대회, 10월 15일-10월 16일, 2020 (온라인 포스터)

-      박지수, 장원식, 김종찬, 이승환, 나군호, 함원식, 전이성 투명세포 신세포암 환자에서 sunitinib 유발 초기 용량 제한 독성 및 생존에 대한 중요한 예측 인자로서의 내장 지방의 역할, 제 72차 대한비뇨의학회 추계학술대회, 10월 15일-10월 16일, 2020 (온라인 포스터)

-      박지수, 장원식, 김종찬, 이승환, 나군호, 함원식, 공격적인 작은 투명세포 신세포암의 예측 인자로서 내장 지방과 DDX11의 연관성, 제 72차 대한비뇨의학회 추계학술대회, 10월 15일-10월 16일, 2020 (온라인 포스터)

-      박지수, 이명은, 박세미, 김병선, 김준석, 황태현, 김대호, 구교철, 김종찬, 장원식, 함원식, Remodeling of tumor microenvironment in lung metastatic sites by oncolytic vaccinia virus in pulmonary metastatic orthotopic renal cell carcinoma murine model, 제 73차 대한비뇨의학회 추계학술대회, 11월 3일-11월 6일, 2021 (구연)

-      박지수, 이명은, 박세미, 조영흔, 김동균, 고종철, 구교철, 김종찬, 장원식, 함원식, Systemic effects of oncolytic vaccinia virus in prevention and regression of lung metastasis in renal cell carcinoma, 제 73차 대한비뇨의학회 추계학술대회, 11월 3일-11월 6일, 2021 (구연)

-      박지수, 강동훈, 조영흔, 방성은, 고종철, 이광석, 장원식, 김종찬 함원식, The association between increased risk of dementia and beta-3 adrenergic receptor agonist or anticholinergics in overactive bladder patients: Korean population-based cohort study, 제 73차 대한비뇨의학회 추계학술대회, 11월 3일-11월 6일, 2021 (구연)

-      박지수, 이명은, 박세미, 정성우, 김강규, 전대영, 김동균, 구교철, 장원식, 김종찬, 함원식, Development of diagnostic biomarkers for aggressive adult Xp11.2 translocation clear cell renal cell carcinoma, 제 73차 대한비뇨의학회 추계학술대회, 11월 3일-11월 6일, 2021 (포스터)

-      박지수, 이명은, 김종찬, 장원식, 구영란, 박세미, 이광석, 강숭구, 한웅규, 최영득, 함원식, The role of cytoreductive nephrectomy with immune checkpoint inhibitor therapies in metastatic renal cell carcinoma, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 이명은, 김종찬, 장원식, 구영란, 박세미, 이광석, 강숭구, 한웅규, 최영득, 함원식, Addition of oncolytic virus is as effective as addition of cytoreductive nephrectomy to the first-line treatment of anti-PD-1/anti-CTLA-4 antibodies in the murine metastatic renal cell carcinoma model, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 김종찬, 장원식, 이광석, 강숭구, 이승환, 한웅규, 최영득, 함원식, Investigation on the effects of the COVID-19 in urinary and stool microbiome with the association of progression of benign prostatic hyperplasia, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 이명은, 김종찬, 장원식, 구영란, 박세미, 이광석, 강숭구, 한웅규, 최영득, 함원식, Development of therapeutic biomarkers for oncolytic vaccinia virus using cell-line derived xenograft mouse model, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 김종찬, 장원식, 이광석, 강숭구, 김홍경, 이승태, 최종락, 최지선, 이승환, 한웅규, 최영득, 함원식, Novel use of circulating tumor DNA to predict renal sinus fat invasion in small renal cell carcinoma, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 김종찬, 장원식, 이광석, 강숭구, 김홍경, 송재우, 이승환, 한웅규, 최영득, 함원식, Genomic profiling of T1a cystic renal cell carcinoma in comparison with T1a clear cell renal cell carcinoma, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 이종수, 김종찬, 장원식, 이광석, 강숭구, 김홍경, 송재우, 이승환, 한웅규, 최영득, 함원식, Differential diagnosis of benign complex cystic renal mass from cystic renal cell carcinoma of ≤4 cm using plasma fibrinogen levels, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      허지은, 조영흔, 전진형, 강숭구, 박지수, 한현호, 이종수, 함원식, 장원식, Intravesical gemcitabine for high risk non-muscle invasive bladder cancer in korea: A preliminary study, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (구연)

-      박지수, 이명은, 김종찬, 장원식, 구영란, 박세미, 이광석, 강숭구, 한웅규, 최영득, 함원식, PSCA (prostate stem cell antigen) as candidate prognostic biomarker for T1a clear cell renal cell carcinoma, 제 74차 대한비뇨의학회 추계학술대회, 10월 5일-10월 8일, 2022 (포스터)

-        박지수, 이명은, 장원식, 김종찬, 함원식, Crosstalk between clear cell renal cell carcinomas and perirenal fat defines tumor aggressiveness, 제 36회 대한비뇨기종양학회 정기학술대회, 8월 26일, 2023 (구연)

-        박지수, 이명은, 장원식, 김종찬, 함원식, The role of cytoreductive nephrectomy in perspectives of tumor immune microenvironment, 제 36회 대한비뇨기종양학회 정기학술대회, 8월 26일, 2023 (구연)

-        박지수, 김종찬, 장원식, 조강수, 이승환, 한웅규, 함원식, Dementia associated with anticholinergic monotherapy or beta-3 agonist monotherapy or combination therapy used for overactive bladder: a population-based Korean national cohort study, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (구연)

-        박지수, 이종수, 이승환, 김종찬, 장원식, 이광석, 구교철, 조강수, 한웅규, 함원식, Development of non-invasive screening biomarkers for small aggressive clear cell renal cell carcinoma, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (구연)

-        박지수, 이명은, 신광모, 정민화, 김종찬, 장원식, 구교철, 이남희, 오근희, 이승환, 한웅규, 한웅규, 함원식, PD-1 inhibitor plus oncolytic virus is effective and safe treatment option for metastatic renal cell carcinomas, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (구연)

-        박지수, 정형오, 이경준, 김종찬, 장원식, 조강수, 이승환, 이세민, 함원식, Single-cell RNA sequencing of BCG-unresponsive non-muscle invasive bladder cancer, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (구연)

-        박지수, 김종찬, 전진형, 이종수, 장원식, 이승환, 한웅규, 구교철, 조강수, 함원식, The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in immune-oncology era (SEVURO-CN): a study protocol for a multi-center, prospective, randomized trial, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (구연)

-        박지수, 신광모, 이명은, 정민화, 김종찬, 장원식, 구교철, 이승환, 한웅규, 함원식, Optimal sequencing of subsequent therapies in cabozantinib-resistant advanced clear cell renal cell carcinomas, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (포스터)

-        박지수, 이명은, 정민화, 신광모, 김종찬, 장원식, 구교철, 이승환, 한웅규, 함원식, Crosstalk between clear cell renal cell carcinomas and adipocytes promotes tumor growth and metastasis in orthotopic murine models, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (포스터)

-        박지수, 이명은, 신광모, 정민화, 김종찬, 장원식, 구교철, 이승환, 윤혜진, 한웅규, 함원식, Investigation of metabolomic profiles of clear cell renal cell carcinomas, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (포스터)

-        박지수, 김종찬, 장원식, 조강수, 구교철, 이종수, 이승환, 한웅규, 함원식, Exploration of the difference in gut microbiome composition between high-grade Ta and T1 bladder cancer, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (포스터)

-        박지수, 이종수, 김종찬, 장원식, 구교철, 조강수, 이광석, 이승환, 한웅규, 함원식, Genetic association between perirenal adipose tissue and clear cell renal cell carcinoma, 제 75차 대한비뇨의학회 추계학술대회, 11월 1일-11월 4일, 2023 (포스터)

-        박지수, 박영지, 김종찬, 장원식, 함원식, HDL-Cholesterol as a Predictor of Disease-Free Survival in Intermediate-High-Risk Clear Cell Renal Cell Carcinoma Post-Nephrectomy: Implications for Ideal Adjuvant Pembrolizumab Selection, 제 37회 대한비뇨기종양학회 정기학술대회, 8월 31일, 2024 (구연)

-        박지수, 석정은, 김종찬, 장원식, 이승환, 한웅규, 최영득, 함원식, Impact of Tumor Regression Following Neoadjuvant Androgen Deprivation Therapy on Oncological Outcomes in Localized Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy, 제 37회 대한비뇨기종양학회 정기학술대회, 8월 31일, 2024 (구연)

-        박지수, 김종찬, 석정은, 장원식, 허지은, 김경환, 남종길, 임범진, 홍범식, 남욱, 오종진, 정승환, 구자현, 노태일, 강석호, 하윤석, 송기현, 서호경, 송완, 성현환, 정병창, 최중원, 함원식, Influence of Gender and Menopausal Status on Recurrence and Prognosis of Bladder Cancer Following Radical Cystectomy: Results from the Korean Bladder Cancer Study Group Database, 제 37회 대한비뇨기종양학회 정기학술대회, 8월 31일, 2024 (구연)

-        박지수, 최수범, 김종찬, 장원식, 함원식, Association of β3-adrenergic Receptor Agonist Mirabegron with Increased Risk of Kidney Cancer in Overactive Bladder Patients: A Nationwide Cohort Study, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 황병진, 김은채, 송설, 이명은, 김종찬, 장원식, 함원식, Immunological Impact of Cytoreductive Nephrectomy in Combination with Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma: Insights from the SEVURO-CN Trial, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 석정은, 김종찬, 장원식, 이승환, 한웅규, 최영득, 함원식, Impact of Tumor Regression Following Neoadjuvant Androgen Deprivation Therapy on Oncological Outcomes in Localized Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 이명은, 김종찬, 장원식, 함원식, Differential Gene Expression in Perirenal Fat and Primary Tumor Tissue as Predictors of Aggressiveness in Clear Cell Renal Cell Carcinoma, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 이명은, 김종찬, 정민선, 장원식, 함원식, Impact of β3-Adrenergic Receptor Agonists on Kidney Cancer Progression and Immune Microenvironment: Insights from a Murine Model, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 황병진, 김은채, 송설, 이명은, 김종찬, 장원식, 함원식, Genetic and Immune Profiling of Aggressive Small Renal Cell Carcinomas Using Bulk and Single-Cell RNA Sequencing, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        김종찬, 박지수, 장원식, 허지은, 김경환, 남종길, 임범진, 홍범식, 남욱, 오종진, 정승환, 구자현, 노태일, 강석호, 하윤석, 송기현, 서호경, 송완, 성현환, 정병창, 최중원, 함원식, Comparative oncologic outcomes of primary versus secondary muscle-invasive bladder cancer following radical cystectomy: Results from the Korean Bladder Cancer Study Group Database, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 김종찬, 석정은, 장원식, 허지은, 김경환, 남종길, 임범진, 홍범식, 남욱, 오종진, 정승환, 구자현, 노태일, 강석호, 하윤석, 송기현, 서호경, 송완, 성현환, 정병창, 최중원, 함원식, Influence of Gender and Menopausal Status on Recurrence and Prognosis of Bladder Cancer Following Radical Cystectomy: Results from the Korean Bladder Cancer Study Group Database, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 이명은, 김종찬, 장원식, Abdulaziz Alanazi, 함원식, Establishment of an ex vivo bladder tumor model for advancing personalized medicine, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (구연)

-        박지수, 박영지, 김종찬, 장원식, 함원식, HDL-Cholesterol as a Predictor of Disease-Free Survival in Intermediate-High-Risk Clear Cell Renal Cell Carcinoma Post-Nephrectomy: Implications for Ideal Adjuvant Pembrolizumab Selection, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

-        박지수, 박영지, 김종찬, 장원식, 함원식, Prognostic Significance of High-Density Lipoprotein Cholesterol in Clear Cell Renal Cell Carcinoma, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

-        박지수, 이명은, 김종찬, 장원식, 함원식, Evaluating the Antitumor Efficacy and Immune Activation Mechanisms of OM-89 in an Orthotopic Bladder Cancer Mouse Model, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

-        박지수, 이지은, 이명은, 김종찬, 장원식, 함원식, The potential anti-cancer activity of dual TTK/PLK1 inhibitor, BAL0891, in bladder cancer, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

-        박지수, 이명은, 김종찬, 장원식, 함원식, Evaluating the Antitumor Efficacy of Lysophosphatidic Acid Receptor 1 (LPA1) Antagonists in Renal Cell Carcinomas: Comparative Analysis with Sunitinib and Cabozantinib, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

-        김종찬, 박지수, 이명은, 장원식, 함원식, Prostate Stem Cell Antigen (PSCA) as a Predictor of Aggressive Small Clear Cell Renal Cell Carcinoma through mTOR Pathway Activation, 제 76차 대한비뇨의학회 추계학술대회, 10월 16일-10월 18일, 2024 (포스터)

• 2013.06.07, The 5th Yonsei University Student Research Festival: Excellence Prize (제5회 연세의대 학생연구축제: 우수상)

• 2013.09.08, The 3rd Asia Federation of Osteoporosis Societies: Traveling Award "Risk prediction of osteoporosis at any site among total hip, femoral neck, or lumbar spine using machine learning and conventional methods"

• 2013.11.02, Korean Neuroscience Association English Speech Award: "Diagnosis of neuromuscular diseases using multicategory classification"

• 2014.06.07, The 6th Yonsei University Student Research Festival: Grand Prize (제6회 연세의대 학생연구축제: 최우수상)

• 2015.04.08, BIO Founding Idea Competition: Excellence Prize (Korea Health Industry Development Agency) (BIO 창업 아이디어 경진대회: 우수상)

• 2015.09.17, Korea Start-up League National Qualification: Excellence Prize (Business Development Agency) (대한민국 창업리그 전국예선: 우수상)

• 2016.02.03, Yonsei University College of Medicine Deans Award in Research Area (연세대학교 의과대학장상: 연구부문)

• 2018.06.15, The 25th Korean Endourology Society Academic Awards - Cumulative sum analysis of learning curve for video-assisted mini-laparotomy partial nephrectomy in renal cell carcinoma (제25차 대한 내비뇨학회 학술대회 학술상)

• 2018.10.07, 38th Congress of the Société Internationale d'Urologie Best Poster Award - Prediction of Chronic Kidney Disease Risk in Patients with Partial Nephrectomy (제38회 세계비뇨기과학회 우수 포스터상)

• 2018.11.29, Participation of International Session II of the 70th Annual Meeting of Korean Urological Association (제70차 대한비뇨기과학회 추계학술대회 국제세션 참여상)

• 2019.02.19, Yonsei University College of Medicine, Severance Hospital, Resident Best Paper Award, 2018 (2018년도 세브란스병원 전공의 우수 논문상)

• 2019.03.20, 34th Annual European Association of Urology (EAU) Congress Best Poster Award - The role of prostatic apex shape in voiding symptom and urine flow: A development and validation study (제34회 유럽비뇨기과학회 우수 포스터상) 

• 2019.08.24, 32nd Annual Korean Urological Oncology Society Best Paper Award - Association Between Prostate Cancer and 25-Hydroxyvitamin D2 Levels: National Health and Nutrition Examination Survey 2007-2008 Results (제32차 대한비뇨종양학회 우수논문상)

• 2019.10.19, 3rd Korean Resident Academic Award (제3회 대한전공의 우수학술상 - 장려상)

• 2020.02.21, Yonsei University College of Medicine, Severance Hospital, Resident Best Paper Award, 2019 (2019년도 세브란스병원 전공의 우수 논문상)

• 2020.02.24, Department of Medical Science, Graduate School of Yonsei University, Academic Award for Excellence (Doctor of Philosophy) (2019학년도 연세대학교 대학원 의학과 우수학술상 (박사))

• 2020.05, Yonsei University College of Medicine, Severance Hospital, Best Resident Awards (연세의료원 모범직원상 (병원장상))

• 2020.06.26, Yonsei University, Graduate School, Thesis Award for academic field of Medicine by the Doctoral thesis – Risk prediction tool for aggressive tumors in clinical T stage clear cell renal cell carcinoma using molecular biomarkers (2020년도 연세대학교 대학원 우수논문상) 

• 2020.08.22, 25th Seoul Medical Association Young Investigator Awards (Resident) (제25회 서울특별시의사회 젊은의학자상 (전공의 부문))

• 2020.09.05, Korean Society of Pediatric Urology Best Paper Award (Korean Ferring Award) – Transurethral incision as initial option in treatment guidelines for ectopic ureteroceles associated with duplex system (대한소아비뇨의학회 우수논문상 (한국 Ferring 상)) 

• 2021.02.16, Yonsei University College of Medicine, Severance Hospital, Resident Best Paper Award, 2020 (2020년도 세브란스병원 전공의 우수 논문상)

• 2021.11.05, 73rd Annual Meeting of Korean Urological Association, Best Abstract Award (Basic science) - Remodeling of tumor microenvironment in lung metastatic sites by oncolytic vaccinia virus in pulmonary metastatic orthotopic renal cell carcinoma murine model  (제73차 대한비뇨의학회 추계학술대회 - 우수초록상 (기초부문))

• 2022.07.27, Startup Contest for Health and Medical Big Data Utilization (Encouragement Award) (2022년 보건의료빅데이터 활용 창업경진대회 (장려상))

• 2022.08.03, Korea Army Training Center Commander Award (Excellence Award) (육군훈련소장 소장상 (우수))

• 2022.09.09, Travel Grant for the ESMO Congress 2022, 9– 13 September 2022 in Paris, France (트래블 그랜트, 유럽종양내과학회 2022, 파리, 프랑스)

• 2022.10.08, 74th Annual Meeting of Korean Urological Association, Best Presentation Award -The role of cytoreductive nephrectomy with immune checkpoint inhibitor therapies in metastatic renal cell carcinoma (제74차 대한비뇨의학회 추계학술대회 - BEST 연제발표상)

• 2022.10.08, 74th Annual Meeting of Korean Urological Association, Best Presentation Award -Differential diagnosis of benign complex cystic renal mass from cystic renal cell carcinoma of ≤4 cm using plasma fibrinogen levels (제74차 대한비뇨의학회 추계학술대회 - BEST 연제발표상)

• 2022.12.27, Certificate of Commendation, Sorokdo National Hospital (Hospital Director's Award) (국립소록도병원 표창장)

• 2023.04.07, Certificate of Commendation, Ministry of Health and Welfare (Minister’s Award) (보건복지부장관 표창장)

• 2023.09.29, Urological Association of Asia (UAA) Congress 2023, Dubai, UAE, Nominated Delegate for Young Leadership Forum (젊은 리더십 포럼 대표, 아시아비뇨의학회 2023, 두바이, 아랍에미리트)

• 2023.11.01, 75th Annual Meeting of Korean Urological Association, Best Presentation Award - Dementia associated with anticholinergic monotherapy or beta-3 agonist monotherapy or combination therapy used for overactive bladder: a population-based Korean national cohort study (제75차 대한비뇨의학회 추계학술대회 - BEST 연제발표상)

• 2023.11.01, 75th Annual Meeting of Korean Urological Association, Best Presentation Award - Development of non-invasive screening biomarkers for small aggressive clear cell renal cell carcinoma (제75차 대한비뇨의학회 추계학술대회 - BEST 연제발표상)

• 2023.12.27, Talent Award of Korea 2023, Ministry of Education (2023년 대한민국 인재상)

• 2013, The 1st Yonsei University SCL Student Research Funds: Exploring Biomarkers of Neuromuscular Disease and Borderline Ovarian Cancer Using Multi-classification Analysis (1회 연세의대 SCL 학생연구비: 다중분류 분석을 이용한 신경근육 질환과 경계성난소암 관련 바이오 마커 탐색)

• 2014, The 2nd Yonsei University SCL Student Research Funds: Study of disease relatedness and related biomarkers of female reproductive cancer (endometrial cancer, fallopian tube, ovarian cancer) using multiple classification analysis (2회 연세의대 SCL 학생연구비: 다중분류 분석을 이용한 여성생식기암(자궁내막암, 난관암, 난소암)의 질병 연관성 연구 및 관련 바이오 마커 탐색)

• 2017–2019, Disease-centered intervention study by Ministry of Health and Welfare: Efficacy evaluation of FOXC2 and CLIP4 as prognostic biomarker for personalized treatment and development of high-risk group prediction model in T1 stage renal cell cancer (보건복지부 질환극복기술개발 사업: T1 병기 신세포 암에서의 개별 맞춤 치료를 위한 예후 바이오마커로서의 FOXC2와 CLIP4의 유효성 평가 및 고위험군 예측 모형의 개발)

• 2019-2021, Advanced research by Korea Research Foundation: Development of molecular prediction model for treatment response of immune checkpoint inhibitor and combination with oncolytic herpes simplex virus using artificial intelligence in metastatic renal cell carcinoma animal model (과학기술정보통신부 중견연구자지원사업: 전이성 신세포암 동물 모델에서 인공 지능을 활용한 면역관문억제제 단독 및 암살상바이러스와의 병합 요법 치료 효과 예측을 위한 분자학적 모델 제작)

• 2020-2021, Yonsei University College of Medicine Research Fund: Optimization of plasma circulating tumor DNA platform as prognostic biomarker in high risk renal cell carcinoma in comparison with single cell genome sequencing (연세대학교 의과대학 교내연구비: 단일 세포 genome 시퀀싱과의 비교를 통한 고위험 신세포암에서의 예후 바이오마커로서의 혈액 내 순환종양 DNA platform의 최적화)

• 2021-2022, Yonsei University College of Medicine Research Fund: Development of therapeutic response prediction model in metastatic clear cell renal cell carcinoma patients using serum multi-omics approach (연세대학교 의과대학 교내연구비: 혈청 멀티오믹스 분석을 통한 전이성 투명세포형 신세포암 환자의 치료 반응 예측 모델 개발)

• 2021-2023, The Korean Urological Association Health Insurance Big Data Analysis Research Project: Comparison of increased risk of dementia between anticholinergics and beta-3 adrenergic receptor agonist in the treatment of overactive bladder patients using the National Health Insurance Corporation data (대한비뇨의학회 건강보험 빅데이터 자료 분석 연구 과제: 국민건강보험공단 데이터를 이용하여 과민성 방광 환자의 치료에 있어 anticholinergics와 beta-3 adrenergic receptor agonist의 치매 유발 위험 비교)

• 2021-2023, The Korean Urological Oncology Society Research Fund (Young Researcher Project): Development of recurrence prediction and therapeutic biomarker and establishment of therapeutic strategy for Xp11.2 translocation renal cell carcinoma by RNA sequencing (2021년 비뇨기종양학회 연구지원 사업 (젊은 연구자 과제): RNA sequencing을 이용하여 성인 Xp11.2 전좌 신세포암 재발 예측 및 치료 바이오마커 탐색을 통한 공격적 Xp11.2 전좌 신세포암에서의 치료 전략 수립)

• 2021-2022, Yonsei University-UNIST Future Preparation Joint Project: Discovery of biomarkers and therapeutic targets for predicting BCG treatment response for bladder cancer based on single-cell transcriptome (연세의대-UNIST 미래준비 공동과제: 단일세포 전사체 기반 방광암의 BCG 치료 반응 예측 바이오마커와 치료 타겟 발굴)

• 2022-2024, Advanced research by Korea Research Foundation: Investigation on modulation of perirenal adipose tissue to enhance therapeutic efficacy of oncolytic virus and immune checkpoint inhibitor combination therapy in metastatic renal cell carcinoma (과학기술정보통신부 중견연구자지원사업: 전이성 신세포암에서 신주위 지방 성분 조절을 통한 암살상 바이러스와 면역관문억제제 병합요법의 치료효과 상승 방향 모색)

• 2022-2023, Sorokdo National Hospital Clinical Research Fund: Development of prediction model for personalized treatment prediction model for patient with benign prostatic hyperplasia associated lower urinary tract symptoms by analyzing the association between gut and urinary microbiome (2022년 국립소록도병원 임상연구지원 사업: 장내 및 비뇨 미생물 유전체와 남성 하부요로증상과의 연관성 분석을 통한 양성 전립선 비대증 환자의 맞춤형 치료법 선택 모델 개발)

• 2022-2024, The Korean Urological Oncology Society Research Fund (Young Researcher Project): Evaluation of second-line treatment strategies for metastatic clear cell renal cell carcinoma with initial treatment failure by development of cabozantinib-resistant cell lines (2022년 비뇨기종양학회 연구지원 사업 (젊은 연구자 과제): 저항성 세포주 제작을 통한 cabozantinib 초회 치료 실패 전이성 투명형 신세포암의 2차 치료 전략 수립 및 평가)

• 2022-2023, Foundation for Korean Urological Association and Hanmi Pharm. Co., Ltd., 2nd High-quality Research Talent Fostering Project: Could BPH-associated LUTS be the long-term effects of COVID-19 (Long COVID)? - Prospective cohort study with gut and urinary microbiome analysis (2022년도 제2차 대한비뇨의학재단-한미 연구인재육성사업 과제: 코로나19 감염 장기 후유증 (롱 코비드)과 양성 전립선 비대증에 의한 하부요로증상과의 연관성 분석 – 장내 및 비뇨 미생물 유전체 분석을 이용한 전향적 코호트 연구) 

• 2023-2024, Yonsei University College of Medicine Research Fund (Basic-Clinical Collaborative Translational Research Fund): Prediction of therapeutic response to neoadjuvant chemotherapy in muscle invasive bladder cancer patients using spatial transcriptomics (연세대학교 의과대학 교내연구비 (기초-임상 협력중개연구비): 공간 전사체 분석을 통한 근침윤성 방광암 환자의 선행항암화학요법 반응 예측)

• 2024-2025, Yonsei University-UNIST Future Preparation Joint Project: Discovery of 4th generation anti-cancer drug treatment strategy and biomarkers for predicting treatment response for clear cell renal cell carcinoma based on multi-omics analysis (연세의대-UNIST 미래준비 공동과제: 멀티오믹스기반 투명세포형 신세포암 4세대 대사항암제 적용 치료 전략 및 치료 반응 예측 바이오마커 발굴)

• 2024-2025, The Korean Urological Oncology Society Research Fund (Young Researcher Project): Evaluation of the Anticancer Effects of Mirabegron in Renal Cell Carcinoma Using an Orthotopic Metastatic Renal Cell Carcinoma Murine Model (2024년 비뇨기종양학회 연구지원 사업 (젊은 연구자 과제): 전이성 신장암 동물 모델을 활용하여 미라베그론 (Mirabegron)의 신장암에서의 항암 효과 확인)